WallStSmart

PetMed Express Inc (PETS)vsRidgetech, Inc. (RDGT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

PetMed Express Inc generates 49% more annual revenue ($179.02M vs $119.94M). RDGT leads profitability with a 10.3% profit margin vs -32.0%. PETS earns a higher WallStSmart Score of 43/100 (D).

PETS

Hold

43

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.3Quality: 5.0

RDGT

Hold

37

out of 100

Grade: F

Growth: 2.7Profit: 5.0Value: 5.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.41
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

PETSUndervalued (+73.5%)

Margin of Safety

+73.5%

Fair Value

$11.21

Current Price

$1.82

$9.39 discount

UndervaluedFair: $11.21Overvalued

Intrinsic value data unavailable for RDGT.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PETS2 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

EPS GrowthGrowth
266.7%10/10

Earnings expanding 266.7% YoY

RDGT3 strengths · Avg: 9.7/10
Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Return on EquityProfitability
30.2%10/10

Every $100 of equity generates 30 in profit

Debt/EquityHealth
0.169/10

Conservative balance sheet, low leverage

Areas to Watch

PETS4 concerns · Avg: 2.8/10
PEG RatioValuation
2.324/10

Expensive relative to growth rate

Market CapQuality
$36.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-100.6%2/10

ROE of -100.6% — below average capital efficiency

Revenue GrowthGrowth
-7.9%2/10

Revenue declined 7.9%

RDGT4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.27M3/10

Smaller company, higher risk/reward

Revenue GrowthGrowth
-11.7%2/10

Revenue declined 11.7%

Altman Z-ScoreHealth
1.412/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : PETS

The strongest argument for PETS centers on Price/Book, EPS Growth.

Bull Case : RDGT

The strongest argument for RDGT centers on Price/Book, Return on Equity, Debt/Equity.

Bear Case : PETS

The primary concerns for PETS are PEG Ratio, Market Cap, Return on Equity.

Bear Case : RDGT

The primary concerns for RDGT are EPS Growth, Market Cap, Revenue Growth.

Key Dynamics to Monitor

PETS profiles as a turnaround stock while RDGT is a declining play — different risk/reward profiles.

PETS carries more volatility with a beta of 0.77 — expect wider price swings.

PETS is growing revenue faster at -7.9% — sustainability is the question.

RDGT generates stronger free cash flow (5M), providing more financial flexibility.

Bottom Line

PETS scores higher overall (43/100 vs 37/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

PetMed Express Inc

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

PetMed Express, Inc., doing business as 1-800-PetMeds, is a pet pharmacy in the United States. The company is headquartered in Delray Beach, Florida.

Ridgetech, Inc.

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

China Jo-Jo Drugstores, Inc. is a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company is headquartered in Hangzhou, the People's Republic of China.

Visit Website →

Want to dig deeper into these stocks?